Detalles de la búsqueda
1.
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo.
Gut
; 72(10): 1838-1847, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788014
2.
Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective.
Semin Cancer Biol
; 86(Pt 3): 997-1007, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34838957
3.
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development.
Br J Cancer
; 128(7): 1391-1399, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36759721
4.
Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study.
Mol Med
; 29(1): 14, 2023 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36717774
5.
Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives.
Int J Mol Sci
; 23(2)2022 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35055006
6.
Downexpression of miR-200c-3p Contributes to Achalasia Disease by Targeting the PRKG1 Gene.
Int J Mol Sci
; 24(1)2022 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36614110
7.
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
Br J Cancer
; 124(1): 183-190, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33024268
8.
Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer.
Future Oncol
; 17(18): 2315-2324, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33663264
9.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164906
10.
Intestinal adenosquamous carcinoma with a synchronous skin metastasis: a immunohistochemical and molecular analysis.
Int J Colorectal Dis
; 35(2): 337-341, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31823050
11.
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.
Pharmacogenomics J
; 19(6): 556-563, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30723313
12.
Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low-Risk, Locally Advanced Rectal Cancer (RaP Study/STAR-03).
Oncologist
; 23(8): 912-918, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29523646
13.
Functional Implications of MicroRNAs in Crohn's Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling.
Int J Mol Sci
; 18(7)2017 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28726756
14.
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study.
J Clin Oncol
; 42(11): 1278-1287, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181312
15.
Mucosal Microbiota from Colorectal Cancer, Adenoma and Normal Epithelium Reveals the Imprint of Fusobacterium nucleatum in Cancerogenesis.
Microorganisms
; 11(5)2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37317121
16.
Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF wild type tumors at start of first line: The CAPRI 2 GOIM trial.
Front Oncol
; 13: 1069370, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36860319
17.
Intrahepatic Cholangiocarcinoma and Acute Intermittent Porphyria: A Case Report.
J Clin Med
; 12(9)2023 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37176532
18.
Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model.
Cell Death Discov
; 9(1): 116, 2023 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37019893
19.
Exploring biological heterogeneity and implications on novel treatment paradigm in BRAF-mutant metastatic colorectal cancer.
Crit Rev Oncol Hematol
; 173: 103657, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35337969
20.
Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models.
Biomed Pharmacother
; 151: 113163, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35617803